Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Gemina Laboratories Ltd (GLAB.CN)
Gemina Laboratories Ltd (GLAB.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 41,311
  • Shares Outstanding, K 73,770
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,979 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade GLAB.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 +12.00%
on 02/16/24
0.5700 -1.75%
on 02/09/24
+0.0700 (+14.29%)
since 01/23/24
3-Month
0.3000 +86.67%
on 12/05/23
0.6000 -6.67%
on 01/04/24
+0.1600 (+40.00%)
since 11/23/23
52-Week
0.2000 +180.00%
on 11/10/23
0.7000 -20.00%
on 03/09/23
-0.1400 (-20.00%)
since 02/23/23

Most Recent Stories

More News
Canadian Securities Exchange Reports August 2023 Performance Figures

Toronto, Ontario--(Newsfile Corp. - September 19, 2023) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for August 2023.August 2023 Operating StatisticsTrading...

ASE.CN : 1.1900 (-4.03%)
DCLI.CN : 0.3300 (-1.49%)
GLAB.CN : 0.5600 (+1.82%)
HEAT.CN : 0.2300 (-8.00%)
LIFT.CN : 7.0000 (-1.41%)
Stocks in play: Gemina Laboratories Ltd

Announces that it has entered into agreement with International Point of Care, Inc, for the manufacturing ...

GLAB.CN : 0.5600 (+1.82%)
Gemina Labs Announces Closing Of Concurrent Private Placement

VANCOUVER, BC / ACCESSWIRE / July 11, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced non-brokered private...

GLAB.CN : 0.5600 (+1.82%)
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement

VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has closed its previously announced "commercially...

GLAB.CN : 0.5600 (+1.82%)
Gemina Announces Filing of Prospectus Supplement

VANCOUVER, BC / ACCESSWIRE / June 24, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has entered into an agency agreement dated...

GLAB.CN : 0.5600 (+1.82%)
Gemina Announces Proposed Financing Up to $5 Million

VANCOUVER, BC / ACCESSWIRE / June 21, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB) (FRA:8I7) is pleased to announce that the Company has engaged Leede Jones Gable Inc., as agent,...

GLAB.CN : 0.5600 (+1.82%)
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor

VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the appointment of Brian Firth as an adviser to the Company.

GLAB.CN : 0.5600 (+1.82%)
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test

- Less than two weeks after announcing the highly successful completion of human trials, Gemina has secured a European Union ("EU") CE Mark, which accelerates commercialization of the breakthrough product...

GLAB.CN : 0.5600 (+1.82%)
Stocks in play: Gemina Laboratories

Announces the successful completion of its human performance study for the Gemina Legio XTM COVID-19 ...

GLAB.CN : 0.5600 (+1.82%)
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

GLAB.CN : 0.5600 (+1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.5733
2nd Resistance Point 0.5667
1st Resistance Point 0.5633
Last Price 0.5600
1st Support Level 0.5533
2nd Support Level 0.5467
3rd Support Level 0.5433

See More

52-Week High 0.7000
Last Price 0.5600
Fibonacci 61.8% 0.5090
Fibonacci 50% 0.4500
Fibonacci 38.2% 0.3910
52-Week Low 0.2000

See More

Business Summary

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar